An observational study to evaluate the prevalence of a cancer immunotherapy target and its role in patients with triple-negative breast cancer treated with systemic therapy (VANESSA)

2022 ◽  
Author(s):  
Trial Information Support Line
Keyword(s):  
Breast Cancer ◽  
Observational Study ◽  
Cancer Immunotherapy ◽  
Triple Negative Breast Cancer ◽  
Systemic Therapy ◽  
Triple Negative ◽  
Immunotherapy Target

De-escalating systemic therapy in triple negative breast cancer: The example of secretory carcinoma

2018 ◽  
Vol 47 (4) ◽  
pp. 163-165 ◽  
Author(s):  
J.-C. Benabu ◽  
F. Stoll ◽  
A. Koch ◽  
S. Molière ◽  
J.-P. Bellocq ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Systemic Therapy ◽  
Triple Negative ◽  
Secretory Carcinoma

scholarly journals Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens

PROTEOMICS ◽  
2018 ◽  
Vol 18 (12) ◽  
pp. 1700465 ◽  
Author(s):  
Nicola Ternette ◽  
Marloes J. M. Olde Nordkamp ◽  
Julius Müller ◽  
Amanda P. Anderson ◽  
Annalisa Nicastri ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Immunotherapy Target
Sign in / Sign up

Export Citation Format

Share Document